TGFBR1 and renal cell carcinoma: To investigate whether altered TGF‐β pathway played a role in the inhibition of RCC proliferation and metastasis by HOOK1, we stimulated RCC cells overexpressing HOOK1 with the ALK5 agonist TGF‐β1.